IO Biotech Statistics
Total Valuation
IO Biotech has a market cap or net worth of $63.25 million. The enterprise value is $5.13 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, before market open.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 51.31% in one year.
Current Share Class | 65.88M |
Shares Outstanding | 65.88M |
Shares Change (YoY) | +51.31% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.34% |
Owned by Institutions (%) | 15.40% |
Float | 31.42M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.35 |
P/TBV Ratio | 1.35 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.04.
Current Ratio | 3.33 |
Quick Ratio | 3.14 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -106.00% and return on invested capital (ROIC) is -64.45%.
Return on Equity (ROE) | -106.00% |
Return on Assets (ROA) | -54.47% |
Return on Invested Capital (ROIC) | -64.45% |
Return on Capital Employed (ROCE) | -197.41% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.19M |
Employee Count | 80 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, IO Biotech has paid $1.44 million in taxes.
Income Tax | 1.44M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.25% in the last 52 weeks. The beta is 0.08, so IO Biotech's price volatility has been lower than the market average.
Beta (5Y) | 0.08 |
52-Week Price Change | -34.25% |
50-Day Moving Average | 0.96 |
200-Day Moving Average | 1.05 |
Relative Strength Index (RSI) | 52.67 |
Average Volume (20 Days) | 146,125 |
Short Selling Information
The latest short interest is 112,344, so 0.17% of the outstanding shares have been sold short.
Short Interest | 112,344 |
Short Previous Month | 128,332 |
Short % of Shares Out | 0.17% |
Short % of Float | 0.36% |
Short Ratio (days to cover) | 0.45 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -95.18M |
Pretax Income | -87.64M |
Net Income | -95.49M |
EBITDA | -94.92M |
EBIT | -95.18M |
Earnings Per Share (EPS) | -$1.45 |
Full Income Statement Balance Sheet
The company has $60.03 million in cash and $1.92 million in debt, giving a net cash position of $58.12 million or $0.88 per share.
Cash & Cash Equivalents | 60.03M |
Total Debt | 1.92M |
Net Cash | 58.12M |
Net Cash Per Share | $0.88 |
Equity (Book Value) | 47.02M |
Book Value Per Share | 0.71 |
Working Capital | 45.47M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$82.35 million and capital expenditures -$44,000, giving a free cash flow of -$82.39 million.
Operating Cash Flow | -82.35M |
Capital Expenditures | -44,000 |
Free Cash Flow | -82.39M |
FCF Per Share | -$1.25 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |